NNVC Stock Summary and Trading Ideas (Nanoviricides | AMEX:NNVC)

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Nanoviricides trades on the AMEX stock market under the symbol NNVC.

As of December 26, 2025, NNVC stock price was flat at $1.19 with 263,328 million shares trading.

NNVC has a beta of 0.27, meaning it tends to be less sensitive to market movements. NNVC has a correlation of 0.01 to the broad based SPY ETF.

NNVC has a market cap of $25.67 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, NNVC traded as high as $3.59 and as low as $.94.

The top ETF exchange traded funds that NNVC belongs to (by Net Assets): VTI, VXF.

NNVC has underperformed the market in the last year with a price return of -21.2% while the SPY ETF gained +16.0%. NNVC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -16.2% and -4.8%, respectively, while the SPY returned +4.6% and +1.5%, respectively.

NNVC support price is $1.12 and resistance is $1.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NNVC shares will trade within this expected range on the day.